Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06426706 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TPVB or SPSIPB in Pain Management After VATS

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 3, 2025 (before its estimated February 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Start date: May 15, 2024 to Jan 3, 2025
    • Primary completion date: Sep 1, 2024 to Feb 15, 2025
    • Study completion date: Sep 1, 2024 to Mar 15, 2025
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
47 trials monitored
See 1 trial at risk
The goal of this clinical trial is to compare the analgesic efficacy of thoracal paravertebral block (TPVB) and serratus posterior superior intercostal plane block (SPSIPB) in patients undergoing video-assisted thoracoscopic surgery (VATS). The main questions it aims to answer are: How will the total perioperative opioid consumption of the patients receiving two different blocks change? How will TPVB and SPSIPB effect the patients' numeric rating scores for pain in the postoperative 24-hour period? How will TPVB and SPSIPB effect the incidence of opioid related side effects? Participants will be divided in two groups: TPVB group will receive a TPVB before the surgery. SPSIPB group will receive a SPSIPB nerve block before the surgery. Researchers will compare the results between the groups to see the postoperative effects concerning opioid consumption as well as the pain scores, respiratory parameters and opioid associated side effects. The hypothesis of this study is that participants receiving SPSIPB for VATS will have a less total opioid consumption 24 hours postoperatively.
Trial Details
NCT Number NCT06426706
Lead Sponsor Koç University
Conditions
(from sponsor)
Video-assisted Thoracoscopic Surgery, Paravertebral Block, Serratus Posterior Superior Intercostal Plane Block, Regional Anesthesia Morbidity
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov